|Chemical and physical data|
|Molar mass||565.697 g/mol|
|3D model (JSmol)|
|(what is this?)|
Cinaciguat (BAY 58-2667) is an experimental drug for the treatment of acute decompensated heart failure.
Mechanism of action
- Riociguat, another drug stimulating sGC, but with a different mechanism
- PDE5 inhibitors act further downstream in the nitric oxide signalling pathway, reducing cyclic GMP degradation.
- Schubert-Zsilavecz, M, Wurglics, M, Neue Arzneimittel 2009
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|